Mobile menu icon
Mobile menu icon Search iconSearch
Search type

Skin inflammation

Dr Amy SaundersWellcome Trust/Royal Society Sir Henry Dale Fellow

Dr Amy Saunders
Tel: +44 (0)161 275 1690




Our research

We study the skin immune system with a particular focus on mechanisms that actively maintain immune cell tolerance in healthy skin.

At barrier sites such as the skin, gut and lung, mechanisms that promote immune tolerance are particularly important, and can regulate the threshold of inflammatory signals required to initiate an immune response.

These tolerogenic mechanisms are required to prevent inappropriate immune cell activation in response to environmental stimuli such as commensal microbes or allergens.

Dysregulation of these mechanisms can lead to inflammatory skin diseases such as psoriasis and atopic dermatitis, and targeting these pathways may represent novel therapeutic strategies for the treatment of such diseases.

We are investigating a number of pathways in skin that are known to be immune-regulatory at other tissue sites. One pathway that we have become particularly interested in involves signalling via the Ig superfamily members CD200 and CD200R1, and we have shown that this pathway is particularly important to maintain the appropriate activation threshold in skin immune cells.

We are also performing screens to uncover novel immune suppressive pathways that are dysregulated in inflammatory skin disease.

Recently, innate lymphoid cells (ILCs) have been implicated in psoriasis pathogenesis through their capacity to produce the cytokine IL-17.

We are investigating pathways that regulate the activity of skin ILCs in healthy skin and may be perturbed in inflamed skin. These pathways may also be of importance to ILCs at other tissue sites.